These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12223223)

  • 1. Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages.
    Llaverías G; Jové M; Vázquez-Carrera M; Sánchez RM; Díaz C; Hernández G; Laguna JC; Alegret M
    Eur J Pharmacol; 2002 Sep; 451(1):11-7. PubMed ID: 12223223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia.
    Raal FJ; Marais AD; Klepack E; Lovalvo J; McLain R; Heinonen T
    Atherosclerosis; 2003 Dec; 171(2):273-9. PubMed ID: 14644397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway.
    Qiu G; Hill JS
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):388-95. PubMed ID: 18427282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
    Wilcox LJ; Barrett PH; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
    Conde K; Pineda G; Newton RS; Fernandez ML
    Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin.
    Llaverias G; Lacasa D; Viñals M; Vázquez-Carrera M; Sánchez RM; Laguna JC; Alegret M
    Biochem Pharmacol; 2004 Jul; 68(1):155-63. PubMed ID: 15183127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes.
    Isusi E; Aspichueta P; Liza M; Hernández ML; Díaz C; Hernández G; Martínez MJ; Ochoa B
    Atherosclerosis; 2000 Dec; 153(2):283-94. PubMed ID: 11164417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the ACAT inhibitor avasimibe (CI-1011).
    Llaverías G; Laguna JC; Alegret M
    Cardiovasc Drug Rev; 2003; 21(1):33-50. PubMed ID: 12595916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat.
    Post SM; Zoeteweij JP; Bos MH; de Wit EC; Havinga R; Kuipers F; Princen HM
    Hepatology; 1999 Aug; 30(2):491-500. PubMed ID: 10421659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atorvastatin on ApoE and ApoC-I synthesis and secretion by THP-1 macrophages.
    Castilho LN; Chamberland A; Boulet L; Davignon J; Cohn JS; Bernier L
    J Cardiovasc Pharmacol; 2003 Aug; 42(2):251-7. PubMed ID: 12883330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
    Tardif JC; Grégoire J; L'Allier PL; Anderson TJ; Bertrand O; Reeves F; Title LM; Alfonso F; Schampaert E; Hassan A; McLain R; Pressler ML; Ibrahim R; Lespérance J; Blue J; Heinonen T; Rodés-Cabau J;
    Circulation; 2004 Nov; 110(21):3372-7. PubMed ID: 15533865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin decreases stearoyl-CoA desaturase gene expression in THP-1 macrophages incubated with oxidized LDL.
    Martín-Fuentes P; García-Otín AL; Calvo L; Gómez-Coronado D; Civeira F; Cenarro A
    Lipids; 2009 Feb; 44(2):115-23. PubMed ID: 18982375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages.
    Saijonmaa O; Nyman T; Fyhrquist F
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1917-21. PubMed ID: 17158648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
    Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
    J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl-coenzyme A: cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines.
    Bemlih S; Poirier MD; El Andaloussi A
    Cancer Biol Ther; 2010 Jun; 9(12):1025-32. PubMed ID: 20404512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
    Bocan TM; Krause BR; Rosebury WS; Mueller SB; Lu X; Dagle C; Major T; Lathia C; Lee H
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):70-9. PubMed ID: 10634802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages.
    Rodriguez A; Usher DC
    Atherosclerosis; 2002 Mar; 161(1):45-54. PubMed ID: 11882316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.